enow.com Web Search

  1. Ad

    related to: patiromer vs kayexalate medication

Search results

  1. Results from the WOW.Com Content Network
  2. Polystyrene sulfonate - Wikipedia

    en.wikipedia.org/wiki/Polystyrene_sulfonate

    Polystyrene sulfonates are a group of medications used to treat high blood potassium. [1] Effects generally take hours to days. [1] They are also used to remove potassium, calcium, and sodium from solutions in technical applications. Common side effects include loss of appetite, gastrointestinal upset, constipation, and low blood calcium. [1]

  3. Potassium binder - Wikipedia

    en.wikipedia.org/wiki/Potassium_binder

    Potassium binders are medications that bind potassium ions in the gastrointestinal tract, thereby preventing its intestinal absorption. This category formerly consisted solely of polystyrene sulfonate, a polyanionic resin attached to a cation, administered either orally or by retention enema to patients who are at risk of developing hyperkalaemia (abnormal high serum potassium levels).

  4. Patiromer - Wikipedia

    en.wikipedia.org/wiki/Patiromer

    Patiromer was generally well tolerated in studies. Side effects that occurred in more than 2% of patients included in clinical trials were mainly gastro-intestinal problems such as constipation, diarrhea, nausea, and flatulence, and also hypomagnesemia (low levels of magnesium in the blood) in 5% of patients, because patiromer binds magnesium in the gut as well.

  5. Sodium zirconium cyclosilicate - Wikipedia

    en.wikipedia.org/wiki/Sodium_zirconium_cyclosilicate

    In the United States, regulatory approval of ZS-9 was rejected by the Food and Drug Administration (FDA) in May 2016, due to issues associated with manufacturing. [16] On 18 May 2018, the FDA approved sodium zirconium cyclosilicate for treatment of adults with hyperkalemia. [17] It was first practically synthesized by UOP in the late 1990s.

  6. Equianalgesic - Wikipedia

    en.wikipedia.org/wiki/Equianalgesic

    Not all medications have a fixed relationship on this scale. Methadone is different from most opioids because its potency can vary depending on how long it is taken. Acute use (1–3 days) yields a potency about 1.5× stronger than that of morphine and chronic use (7 days+) yields a potency about 2.5 to 5× that of morphine.

  7. Hyperkalemia - Wikipedia

    en.wikipedia.org/wiki/Hyperkalemia

    [42] [43] [44] There are no systematic studies (>6 months) looking at the long-term safety of this medication. [45] Patiromer is taken by mouth and works by binding free potassium ions in the gastrointestinal tract and releasing calcium ions for exchange, thus lowering the amount of potassium available for absorption into the bloodstream and ...

  8. Proton-pump inhibitor - Wikipedia

    en.wikipedia.org/wiki/Proton-pump_inhibitor

    Most of these medications are benzimidazole derivatives, related to omeprazole, but imidazopyridine derivatives such as tenatoprazole have also been developed. [77] Potassium-competitive inhibitors such as revaprazan reversibly block the potassium-binding site of the proton pump, acting more quickly, but are not available in most countries.

  9. Kayexalate - Wikipedia

    en.wikipedia.org/?title=Kayexalate&redirect=no

    Language links are at the top of the page. Search. Search

  1. Ad

    related to: patiromer vs kayexalate medication